Patent Application for Nitrogen-Containing Heterocyclic Derivative Inhibitor

ChangeBridge: Patent Apps - Organic Chemistry (C07D)

Published December 1st, 2025

Detected March 26th, 2026

Summary

The USPTO has published a patent application (US20260085045A1) for a nitrogen-containing heterocyclic derivative inhibitor. The application details a compound, its preparation method, and its use in treating diseases such as cardiovascular and cerebrovascular conditions.

View original document View source feed page

What changed

This document is a publication of a patent application filed with the USPTO, specifically application number US20260085045A1. The application describes a nitrogen-containing heterocyclic derivative inhibitor, including its general formula (I), a method for its preparation, and its potential use in pharmaceutical compositions for treating diseases like cardiovascular and cerebrovascular conditions.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future intellectual property rights and may inform research and development strategies for companies in the pharmaceutical and biotechnology sectors. Companies involved in developing treatments for cardiovascular or cerebrovascular diseases should monitor the progress of this patent application and related filings.

Source document (simplified)

← USPTO Patent Applications

NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF

Application US20260085045A1 Kind: A1 Mar 26, 2026

Inventors

Jiaqiang DONG, Xinxian DENG, Wensheng YU, Fangfang JIN, Zhen GONG

Abstract

A nitrogen-containing heterocyclic derivative inhibitor, a preparation method therefor and the use thereof. Specifically disclosed are a compound as represented by general formula (I), a preparation method therefor, a pharmaceutical composition containing the compound, and the use thereof as an inhibitor in treating diseases such as cardiovascular and cerebrovascular diseases, wherein the definition of each substituent in the general formula (I) are the same as those defined in the description.

CPC Classifications

C07D 213/75 A61K 31/444 A61K 31/497 A61K 31/4985 A61K 31/501 A61K 31/506 A61K 31/517 A61K 31/519 A61K 31/52 A61K 31/53 A61K 31/541 A61K 31/55 A61K 31/551 A61K 31/553 C07D 401/12 C07D 401/14 C07D 405/14 C07D 413/14 C07D 417/14 C07D 471/04 C07D 473/32 C07D 487/04 C07D 491/048 C07D 491/052 C07D 498/14 C07D 513/04 C07D 519/00